Literature DB >> 23735731

Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value.

Laura Marconato1, Valeria Martini, Luca Aresu, Michele Sampaolo, Fabio Valentini, Valentina Rinaldi, Stefano Comazzi.   

Abstract

The aims of this study were to assess the prognostic significance of bone marrow (BM) infiltration in canine large B cell lymphoma (LBCL) and to establish cut-off values for designating the BM as infiltrated by lymphoid blasts. The degree of BM infiltration by large CD21 positive cells in dogs with LBCL was assessed by flow cytometry (FC) and related to time to progression (TTP) and lymphoma-specific survival (LSS). Forty-six dogs were prospectively enrolled, staged and treated with a dose-intense chemotherapeutic protocol. BM infiltration was directly correlated with peripheral blood infiltration (P=0.001), high lactate dehydrogenase activity (P=0.0024) and substage b disease (P<0.001). In the univariate analysis, there was a significant association between BM infiltration diagnosed by FC and both TTP (P=0.001) and LSS (P<0.001). Substage was the only factor associated with TTP in the multivariate analysis (P=0.002), whereas substage (P<0.001) and anaemia (P=0.008) were associated with LSS. A cut-off of 3% BM infiltration had the strongest prognostic value, since it discriminated between dogs with a poorer prognosis (median TTP 69 days; median LSS 155 days) and dogs with a better prognosis (median TTP 149 days; median LSS 322 days). BM analysis is an essential step in the staging of LBCL. The presence of BM infiltration by FC at diagnosis is a negative prognostic indicator in canine LBCL.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone marrow; Canine; Flow cytometry; Large B cell lymphoma; Prognosis

Mesh:

Year:  2013        PMID: 23735731     DOI: 10.1016/j.tvjl.2013.05.003

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  13 in total

Review 1.  Barking up the right tree: advancing our understanding and treatment of lymphoma with a spontaneous canine model.

Authors:  Dania Villarnovo; Angela L McCleary-Wheeler; Kristy L Richards
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

2.  Tumor staging in a Beagle dog with concomitant large B-cell lymphoma and T-cell acute lymphoblastic leukemia.

Authors:  Alessandro Ferrari; Marzia Cozzi; Luca Aresu; Valeria Martini
Journal:  J Vet Diagn Invest       Date:  2021-04-22       Impact factor: 1.279

3.  Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.

Authors:  Dammy Pinheiro; Yu-Mei Chang; Hannah Bryant; Balazs Szladovits; Tim Dalessandri; Lucy J Davison; Elizabeth Yallop; Emily Mills; Chiara Leo; Ana Lara; Anneliese Stell; Gerry Polton; Oliver A Garden
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

Review 4.  Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma.

Authors:  Luca Aresu
Journal:  Front Vet Sci       Date:  2016-08-31

Review 5.  CSPG4: a prototype oncoantigen for translational immunotherapy studies.

Authors:  Valeria Rolih; Giuseppina Barutello; Selina Iussich; Raffaella De Maria; Elena Quaglino; Paolo Buracco; Federica Cavallo; Federica Riccardo
Journal:  J Transl Med       Date:  2017-07-01       Impact factor: 5.531

6.  Myoclonus and hypercalcemia in a dog with poorly differentiated lymphoproliferative neoplasia.

Authors:  Cassia H Z Hare; Joy Archer; Emilie Cloup; Marie-Aude Genain; Katherine Hughes; Katie E McCallum; Lisa Alves
Journal:  J Vet Intern Med       Date:  2018-12-18       Impact factor: 3.333

7.  Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers.

Authors:  Laura Marconato; Luca Aresu; Damiano Stefanello; Stefano Comazzi; Valeria Martini; Roberta Ferrari; Fulvio Riondato; Nicole Rouquet; Patrick Frayssinet; Silvia Sabattini
Journal:  J Immunother Cancer       Date:  2019-06-07       Impact factor: 13.751

8.  Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.

Authors:  Pierre Boyé; Franck Floch; François Serres; Kévyn Geeraert; Pierre Clerson; Xavier Siomboing; Mattias Bergqvist; Gabriel Sack; Dominique Tierny
Journal:  J Vet Intern Med       Date:  2019-05-25       Impact factor: 3.333

9.  Demographic and clinical characteristics of dogs with centroblastic lymphoma.

Authors:  Katarzyna Kliczkowska-Klarowicz; Dariusz Jagielski; Michał Czopowicz; Rafał A Sapierzyński
Journal:  Vet World       Date:  2021-01-07

10.  Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network study.

Authors:  Stefano Comazzi; Stefano Marelli; Marzia Cozzi; Rita Rizzi; Riccardo Finotello; Joaquim Henriques; Josep Pastor; Frederique Ponce; Carla Rohrer-Bley; Barbara C Rütgen; Erik Teske
Journal:  BMC Vet Res       Date:  2018-08-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.